A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients

NCT00002000 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Herpes Simplex
HIV Infections

Interventions

DRUG: Valacyclovir hydrochloride
DRUG: Acyclovir

Sponsor

Glaxo Wellcome